Trade

with

Cambrex Corp
(NYSE: CBM)
AdChoices
18.10
+0.31
+1.74%
After Hours :
18.10
0.00
0.00%

Open

18.00

Previous Close

17.79

Volume (Avg)

220.79k (262.19k)

Day's Range

17.85-18.29

52Wk Range

15.20-23.88

Market Cap.

555.31M

Dividend Rate ( Yield )

-

Beta

0.69

Shares Outstanding

30.68M

P/E Ratio (EPS)

15.36 (1.06)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Biotechnology
Highlights
Analyst Recommendation: Outperform
    • Revenue

    • 318.18M

    • Net Income

    • 25.92M

    • Market Cap.

    • 555.31M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 9.61

    • PEG (Price/Earnings Growth) Ratio

    • 1.72

    • Beta

    • 0.69

    • Forward P/E

    • 13.79

    • Price/Sales

    • 1.61

    • Price/Book Value

    • 2.32

    • Price/Cash flow

    • 12.79

      • EBITDA

      • 72.10M

      • Return on Capital %

      • 7.27

      • Return on Equity %

      • 16.06

      • Return on Assets %

      • 7.27

      • Book Value/Share

      • 7.68

      • Shares Outstanding

      • 30.68M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • 0.03 (1/31/2007)

      • Dividend Declaration Date

      • 1/26/2007

      Analyst Recommendation
      10/21/2014
      Outperform
        • 1 Year Price Target

        • 27.00

        • Credit Rating

        • -

        • Analysts

        • 2

        • EPS Estimate

        • -

        • Cashflow Estimate

        • 2.05

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 56.70

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -52.10

          • 17.04

          • Net Income

            Q/Q (last year)

          • 532.20

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • 5.01

          • 63.43

          • Net Income

            5-Year Annual Average

          • 30.70

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 31.61

            • 82.75

            • Pre-Tax Margin

            • 10.79

            • 39.38

            • Net Profit Margin

            • 9.61

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • 30.70

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 9.90

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • 8.70

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.31

              • 0.76

              • Current Ratio

              • 2.17

              • 2.92

              • Quick Ratio

              • 1.03

              • 2.35

              • Interest Coverage

              • -

              • 38.02

              • Leverage Ratio

              • 2.02

              • 2.21

              • Book Value/Share

              • 7.68

              • 4.79

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 15.06

                • 243.90

                • P/E Ratio 5-Year High

                • 20.27

                • 634.30

                • P/E Ratio 5-Year Low

                • 2.42

                • 124.82

                • Price/Sales Ratio

                • 1.60

                • 9.29

                • Price/Book Value

                • 2.31

                • 8.39

                • Price/Cash Flow Ratio

                • 12.79

                • 49.75

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • 0.00

                    • Dividend Date

                    • 1/26/2007

                    • Ex-Dividend Date

                    • 1/31/2007

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • 16.06

                        (18.50)

                      • 37.63

                        (27.20)

                      • Return on Assets %

                        (5-Year Average)

                      • 7.27

                        (6.40)

                      • 17.22

                        (13.81)

                      • Return on Capital %

                        (5-Year Average)

                      • 11.55

                        (11.00)

                      • 21.78

                        (17.31)

                      • Income/Employee

                      • 35.39k

                      • 117.08k

                      • Inventory Turnover

                      • 2.36

                      • 1.48

                      • Asset Turnover

                      • 0.76

                      • 0.55

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      49.63M
                      Operating Margin
                      15.60
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      12.79
                      Ownership

                      Institutional Ownership

                      -

                      Top 10 Institutions

                      37.91%

                      Mutual Fund Ownership

                      46.31%

                      Float

                      87.40%

                      5% / Insider Ownership

                      3.94%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Heartland Value Fund

                      •  

                        1,000,000

                      • -6.23

                      • 3.26

                      • Walthausen Small Cap Value Fund

                      •  

                        660,134

                      • 23.84

                      • 2.15

                      • iShares Core S&P Small-Cap (AU)

                      •  

                        616,743

                      • 0.24

                      • 1.92

                      • Vanguard Total Stock Mkt Idx

                      •  

                        474,662

                      • 0.55

                      • 1.55

                      • iShares Russell 2000 (AU)

                      •  

                        469,038

                      • -0.89

                      • 1.46

                      • Trans Small Cap Growth Fund

                      •  

                        451,136

                      • 53.45

                      • 1.47

                      • Loomis Sayles Small Cap Growth Fund

                      •  

                        390,741

                      • -3.58

                      • 1.27

                      • TIAA-CREF Small-Cap Equity

                      •  

                        317,055

                      • 41.70

                      • 1.03

                      • DFA U.S. Micro Cap Portfolio

                      •  

                        305,602

                      • 0.00

                      • 1.00

                      • Vanguard Extended Market Index Fund

                      •  

                        295,176

                      • 0.74

                      • 0.96

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • BlackRock Fund Advisors

                      •  

                        1,636,211

                      • -5.23%

                      • 5.33

                      • Ranger Investment Management, L.P.

                      •  

                        1,428,792

                      • +47.67%

                      • 4.66

                      • Dimensional Fund Advisors, Inc.

                      •  

                        1,385,844

                      • +6.31%

                      • 4.52

                      • Acadian Asset Management LLC

                      •  

                        1,214,548

                      • +0.68%

                      • 3.96

                      • Vanguard Group, Inc.

                      •  

                        1,152,574

                      • +2.15%

                      • 3.76

                      • Penn Capital Management CO Inc

                      •  

                        1,100,662

                      • -16.93%

                      • 3.59

                      • Heartland Advisors, Inc.

                      •  

                        1,000,000

                      • -6.23%

                      • 3.26

                      • Silvercrest Asset Management Group LLC

                      •  

                        970,854

                      • +4.61%

                      • 3.16

                      • Thompson, Siegel & Walmsley LLC

                      •  

                        877,598

                      • -0.19%

                      • 2.86

                      • Walthausen & Co., LLC

                      •  

                        862,304

                      • +23.29%

                      • 2.81

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Biotechnology

                      Type

                      Aggressive Growth

                      Style

                      Small Core

                      Cambrex Corp was incorporated as a Delaware corporation in 1981 and began business in December 1981. It is a life sciences company that provides products and services that accelerate and improve the development and commercialization ...moreof new and generic therapeutics. The Company primarily supplies its products and services worldwide to innovator and generic pharmaceutical companies. The Company has three operating segments, which are manufacturing facilities that have been aggregated as one reportable segment. The Company participates in markets that serve the healthcare industry. Customers include generic drug companies and companies that discover and commercialize new small molecule human therapeutics using organic chemistry. The Company uses its technical expertise in a wide range of chemical proce...moresses to meet the needs of its customers for high quality products and services for specialized applications. The Company’s business is primarily comprised of the custom development and manufacture of pharmaceutical ingredients derived from organic chemistry. Products and services are supplied globally to innovator and generic drug companies. Products include APIs, pharmaceutical intermediates and, to a lesser extent, other fine chemicals. The Company’s products and services are sold to a diverse group of several hundred customers, with one customer, Gilead Sciences, Inc. The manufacturing of pharmaceutical products is subject to extensive regulation by governmental authorities, including the FDA, the European Medicines Agency and comparable regulatory authorities in other countries.lessless

                      Key People

                      Steven M. Klosk

                      CEO/Director/President

                      Shlomo Yanai

                      Director/Chairman of the Board

                      Gregory P. Sargen

                      CFO/Executive VP

                      Aldo Magnini

                      Managing Director, Subsidiary

                      Mr. Shawn P. Cavanagh

                      COO/Executive VP

                      • Cambrex Corp

                      • One Meadowlands Plaza

                      • East Rutherford, NJ 07073

                      • USA.Map

                      • Phone: +1 201 804-3000

                      • Fax: +1 201 804-9852

                      • cambrex.com

                      Incorporated

                      1981

                      Employees

                      936

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: